Academic Journal

Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

التفاصيل البيبلوغرافية
العنوان: Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study
المؤلفون: Brück, P, Kisro, J, Cohn, AL, Yoshino, T, Van Cutsem, E, Hegewisch-Becker, S, Kullmann, F, Liepa, AM, Yang, L, Nasroulah, F, Tabernero, J
المصدر: Value in Health ; volume 20, issue 9, page A871 ; ISSN 1098-3015
بيانات النشر: Elsevier BV
سنة النشر: 2017
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jval.2017.08.2552
الاتاحة: http://dx.doi.org/10.1016/j.jval.2017.08.2552
https://api.elsevier.com/content/article/PII:S1098301517328863?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301517328863?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.68678FD6
قاعدة البيانات: BASE